Bios I Pharma ApS: Financial statements 2016
CVR: 32672620
Source: annual report 2016, Danish Business Authority
01/07/2015 – 30/06/2016
Bios I Pharma ApS (CVR 32672620) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -6,275 and a net result of DKK -1,621 compared with DKK -2,341 the year before. Equity in the 2016 report amounted to DKK 111,652. The solvency ratio was 90.3%.
- Gross Profit
- DKK -6,275
- Profit/Loss
- DKK -1,621
- Equity
- DKK 111,652
- Total Assets
- DKK 123,652
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | -6K | -2K | 112K | - |
| 2015 | - | -7K | -2K | 113K | - |
| 2014 | - | -7K | -2K | 116K | - |
| 2013 | - | -7K | -4K | 118K | - |
Official annual report
Find more companies like Bios I Pharma ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2016
As of November 14, 2016, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of Bios I Pharma ApS.
As of November 14, 2016, Grant Thornton, Godkendt Revisionspartnerselskab has stepped down as auditor of Bios I Pharma ApS.
As of November 14, 2016, Jens Henrik Haaning is registered as director of Bios I Pharma ApS.
As of November 14, 2016, Henrik Lasse Lindblad has stepped down as director of Bios I Pharma ApS.
About Bios I Pharma ApS
Bios I Pharma ApS is a Danish company of the type Anpartsselskab based in Aarhus N, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named AC 01 ApS. The management consists of Henrik Beier Jessen. The company is owned by Beier Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -68,061 and a net result of DKK 206,285 compared with DKK 1,732,448 the year before. Equity in the 2025 report amounted to DKK 445,202.